Peripheral Artery Disease

Disease

Disease Profile

Peripheral artery disease is an atherosclerotic vascular disease in which narrowed peripheral arteries reduce blood flow, most often to the legs, causing claudication and increased cardiovascular risk.

Category
cardiovascular disease
Prevalence
About 6.5 million people age 40 and older in the U.S. are estimated to have PAD.

Related News

Oral Semaglutide Shows Broad Cardiometabolic Benefits in Type 2 Diabetes Trial

Oral semaglutide demonstrated significant improvements in multiple cardiometabolic risk factors in adults with type 2 diabetes at high cardiovascular risk. The SOUL trial analysis showed reductions in systolic blood pressure, cholesterol, triglycerides, HbA1c, and body weight compared to placebo. These benefits were observed as early as 13 weeks and contributed to a 14% reduction in major adverse cardiovascular events.

Related Clinical Trials

NCT ID Title Status Phase
NCT07575568

Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen

NOT_YET_RECRUITING NA
NCT07397390

an Observational Study Evaluting the Effectiveness and Safety of DKutting LL Noval Scoring Balloon Angioplasty for Vessel Preparation Facilitated by IVUS on the Lower Limb Ischemia Patients With Calcified Lesions

ENROLLING_BY_INVITATION
NCT07374601

The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease

RECRUITING
NCT07283289

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

RECRUITING
NCT07209527

Truway Diagnostic Tools in Primary Care

ENROLLING_BY_INVITATION EARLY_PHASE1
NCT07012070

Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers

RECRUITING NA
NCT06917547

Study on PAD and CAS Based on Omics and Imaging

NOT_YET_RECRUITING
NCT06890208

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

RECRUITING
NCT06734221

STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions

RECRUITING NA
NCT06686121

Improving Mobility After Revascularization in Peripheral Artery Disease

RECRUITING PHASE3